SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
DATE OF REPORT - November 4, 2004
(Date of Earliest Event Reported)
COLUMBIA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Commission File No. 1-10352
Delaware | | 59-2758596 |
(State of Incorporation) | | (I.R.S. EmployerIdentification No.) |
| | |
| | |
354 Eisenhower Parkway Livingston, New Jersey | | 07039 |
(Address of principalexecutive offices) | | Zip Code |
Registrant’s telephone number, including area code: (973) 994-3999
ITEM 2.02 Results of Operations and Financial Condition.
On November 4, 2004, Columbia Laboratories, Inc., issued a press release announcing its financial results for the quarter ended September 30, 2004. A copy of this release is attached hereto as Exhibit 99.1.
ITEM 9.01 Exhibits
(c) Exhibits: The information in Exhibit 99.1 is being furnished pursuant to Item 2.02.
Exhibit Number | | Description |
| | |
99.1 | | Press Release dated November 4, 2004, entitled “Columbia Laboratories Reports Third Quarter 2004 Financial Results”. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | |
| COLUMBIA LABORATORIES, INC. |
| | |
Date: November 4, 2004 | By: | /s/ David L. Weinberg |
| David L. Weinberg |
| Vice President and Chief Financial Officer |
Exhibit Index
Exhibit Number | | Exhibit Description |
| | |
99.1 | | Press Release dated November 4, 2004, entitled “Columbia Laboratories Reports Third Quarter 2004 Financial Results”. |